ISRG · 10-Q · 2026Q2 · Full report

Strategic Initiatives

INTUITIVE SURGICAL INC · 2026-07-21 · Importance 68 · Surprise 58

Intuitive’s principal product-development initiatives include its multi-port, Ion, and SP platforms, digital products and services, and other research projects. Research and development expense increased 18% to $370.6 million in the second quarter of 2026 and 16% to $732.5 million for the first six months, driven by expanded product-development activity and higher personnel costs. Management expects substantial continued investment and anticipates research and development expense will continue to increase as the broader portfolio advances.